NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a leader in the development and commercialization of novel cancer therapeutics, today announced that it has appointed John H. Johnson as its Chief Executive Officer, effective August 27, 2007.
